These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 6,7-Dichloroquinoxaline-2,3-dione is a competitive antagonist specific to strychnine-insensitive [3H]glycine binding sites on the N-methyl-D-aspartate receptor complex. Ogita K, Yoneda Y. J Neurochem; 1990 Feb 25; 54(2):699-702. PubMed ID: 1967633 [Abstract] [Full Text] [Related]
3. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Foster AC, Wong EH. Br J Pharmacol; 1987 Jun 25; 91(2):403-9. PubMed ID: 2886170 [Abstract] [Full Text] [Related]
4. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors. Danysz W, Fadda E, Wroblewski JT, Costa E. Mol Pharmacol; 1989 Dec 25; 36(6):912-6. PubMed ID: 2574820 [Abstract] [Full Text] [Related]
11. CGP 31358 binds to a site on the NMDA receptor that is coupled to both the transmitter recognition site and the channel domain. Baud J, Thedinga K, Portet C, Schmutz M, Bittiger H, Bischoff S, Hauser K, Benedict M, Meier R, Fagg GE. Neurosci Lett; 1989 Dec 15; 107(1-3):184-8. PubMed ID: 2575726 [Abstract] [Full Text] [Related]
13. Mode of binding of [3H]dibenzocycloalkenimine (MK-801) to the N-methyl-D-aspartate (NMDA) receptor and its therapeutic implication. Kloog Y, Nadler V, Sokolovsky M. FEBS Lett; 1988 Mar 28; 230(1-2):167-70. PubMed ID: 2895019 [Abstract] [Full Text] [Related]